Literature DB >> 26182682

Epidemiology of Anaphylaxis: Contributions From the Last 10 Years.

M Moro-Moro, M V Múgica-García.   

Abstract

Knowledge of the epidemiology of anaphylaxis has improved during the last 10 years thanks to the increased number of publications with improved methodological robustness. Consequently, we better understand the distribution and frequency of anaphylaxis and the characteristics of fatal anaphylaxis. We now know that anaphylaxis is more frequent than previously thought (up to 50-103 cases per 100 000 person-years), although the distribution differs with the age group (up to 3 times in patients aged 0-4 years), cause (food-induced anaphylaxis is more frequent in young people, drug-induced and Hymenoptera anaphylaxis in older patients), and geographical area (more prevalent in areas with less sunlight). A controversial and unresolved issue is whether this high incidence of anaphylaxis is a real increase or merely the result of better identification of anaphylaxis by the attending physician. Recurrence of anaphylaxis has been recorded in one-third of cases, although it is the least studied area of the epidemiology of anaphylaxis. Fatal anaphylaxis, on the other hand, has been widely studied. We know that death from anaphylaxis is a rare and extraordinary event (0.12 to 1.06 deaths per million person-years) and more likely in older individuals in the case of drug and Hymenoptera anaphylaxis. Studies conducted during the last 10 years are highly powered since they include large numbers of patients (national records of hospitalized patients) over long time periods (10-20 years) or have been conducted with representative samples of the general population.

Entities:  

Mesh:

Year:  2015        PMID: 26182682

Source DB:  PubMed          Journal:  J Investig Allergol Clin Immunol        ISSN: 1018-9068            Impact factor:   4.333


  13 in total

1.  Anaphylaxis after vaccination reported to the Vaccine Adverse Event Reporting System, 1990-2016.

Authors:  John R Su; Pedro L Moro; Carmen S Ng; Paige W Lewis; Maria A Said; Maria V Cano
Journal:  J Allergy Clin Immunol       Date:  2019-01-14       Impact factor: 10.793

2.  Early Use of ECMO for Refractory Kounis Syndrome Concealed by General Anesthesia-A Case Report.

Authors:  Ho Kyung Yu; Miyeong Park; Soo Hee Lee; Jung-Woo Woo; Dong-Hoon Kang; Joung Hun Byun; Seong-Ho Ok
Journal:  Medicina (Kaunas)       Date:  2022-06-02       Impact factor: 2.948

3.  Characteristics of anaphylaxis patients who visited emergency departments in Korea: Results from a national emergency department information system.

Authors:  Mi-Hee Lee; Eui-Jeong Roh; Yu-Mi Jung; Youngmin Ahn; Eun Hee Chung
Journal:  PLoS One       Date:  2022-04-29       Impact factor: 3.240

4.  Anaphylaxis in Poland: the epidemiology and direct costs.

Authors:  Karina Jahnz-Rozyk; Filip Raciborski; Andrzej M Śliwczyński; Anna Kłak; Jarosław Pinkas
Journal:  Postepy Dermatol Alergol       Date:  2017-12-31       Impact factor: 1.837

5.  Cefuroxime-induced anaphylaxis with prominent central nervous system manifestations: A case report.

Authors:  Jianqing Gu; Shuang Liu; Yuxiang Zhi
Journal:  J Int Med Res       Date:  2018-12-07       Impact factor: 1.671

6.  Anaphylaxis to Agaricus bisporus ingestion.

Authors:  Inês Machado Cunha; Maria Luís Marques; Carmo Abreu; Borja Bartolomé; Eva Gomes
Journal:  Einstein (Sao Paulo)       Date:  2020-11-27

7.  Comorbidities and Cofactors of Anaphylaxis in Patients with Moderate to Severe Anaphylaxis. Analysis of Data from the Anaphylaxis Registry for West Pomerania Province, Poland.

Authors:  Iwona Poziomkowska-Gęsicka; Magdalena Kostrzewska; Michał Kurek
Journal:  Int J Environ Res Public Health       Date:  2021-01-05       Impact factor: 3.390

8.  Risk factors of beta-lactam anaphylaxis in Korea: A 6-year multicenter retrospective adult case-control study.

Authors:  Chan Sun Park; Min-Suk Yang; Dong-Yoon Kang; Hye Jung Park; So-Young Park; Young-Hee Nam; Sujeong Kim; Jae-Woo Jung; Hye-Kyung Park; Hye-Ryun Kang
Journal:  World Allergy Organ J       Date:  2021-09-08       Impact factor: 4.084

9.  Who has anaphylaxis in Brazil? Validation of a questionnaire for population studies.

Authors:  Elaine Gagete; Lucilene Delazari Dos Santos; Leticia Gomes de Pontes; Fábio Morato Castro
Journal:  World Allergy Organ J       Date:  2017-11-08       Impact factor: 4.084

10.  Prevalence triggers and clinical severity associated with anaphylaxis at a tertiary care facility in Saudi Arabia: A cross-sectional study.

Authors:  Raghad Alkanhal; Ibrahim Alhoshan; Sadal Aldakhil; Nouf Alromaih; Nesrin Alharthy; Mahmoud Salam; Adel F Almutairi
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.